Cancer

April 14, 2016

Pietenpol named Executive Vice President for Research

Jennifer Pietenpol, Ph.D., director of the Vanderbilt-Ingram Cancer Center, B.F. Byrd Jr. Professor of Molecular Oncology and Professor of Biochemistry, Cancer Biology and Otolaryngology, has been named Executive Vice President for Research at Vanderbilt University Medical Center (VUMC). Her appointment is effective May 1.

By John Howser
April 14, 2016

Switching breast cancer off

Signaling by a receptor that is overexpressed in aggressive forms of breast cancer has been linked to glutamine metabolism, suggesting new anti-cancer therapeutic targets.

By Marilyn Holt
April 13, 2016

Free head and neck cancer screening April 15

The symptoms of head and neck cancer can be subtle. To help catch the disease in its earliest stages, the Vanderbilt Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center will offer free head and neck cancer screenings Friday, April 15.

By VUMC News and Communications
April 7, 2016

Pietenpol named to NCI Blue Ribbon Panel

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), has been selected to serve on a Blue Ribbon Panel that will inform the scientific direction and goals at the National Cancer Institute (NCI) for Vice President Joe Biden’s National Cancer Moonshot Initiative.

By VUMC News and Communications
April 7, 2016

Annual free screening for head and neck cancer set for April 15

The symptoms of head and neck cancer can be subtle, so to help catch the disease in its earliest stages the Vanderbilt Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center will offer free head and neck screenings Friday, April 15, from 9 a.m. to 3 p.m.

By VUMC News and Communications
March 24, 2016

Singer’s concert honors care received at Cancer Center

A cancer patient’s gratitude toward his Vanderbilt-Ingram Cancer Center (VICC) physician led to a star-studded concert to benefit the Cancer Center.

By VUMC News and Communications
March 17, 2016

Study suggests cancer’s ‘clock’ can be rewound

Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented.
By Bill Snyder
March 17, 2016

Multi-institution cancer symposium set for April 2

The Meharry Medical College, Vanderbilt-Ingram Cancer Center, Tennessee State University Cancer Partnership will host the 15th Annual Cancer Retreat, Saturday, April 2, 8:30 a.m. – 3 p.m. The retreat will be held on the Meharry Medical College campus, Harold D. West Basic Sciences Building, Room M001.
By VUMC News and Communications
March 17, 2016

One Million Strong event to raise awareness about colorectal cancer

Thousands of colorectal patients, families and supporters will gather in Nashville April 1 and 2 for the annual One Million Strong event to raise awareness about colorectal cancer.
By VUMC News and Communications
March 3, 2016

Melanoma response to immune therapy

Melanoma-specific expression of a certain protein identifies tumors that are more responsive to an immune therapy.
By Leigh MacMillan
March 3, 2016

First VICC cancer patient treated with new immunotherapy

For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system.
By VUMC News and Communications
February 25, 2016

Chemo better option following pancreatic cancer surgery: study

A multicenter study led by Vanderbilt University Medical Center (VUMC) investigators found that pancreatic cancer patients who underwent surgery and received chemotherapy lived longer and had fewer cancer recurrences in other parts of the body than patients who also received chemoradiation therapy.
By VUMC News and Communications
February 18, 2016

Combining treatments for melanoma

Combining therapies for melanoma that induce cell senescence and that activate the immune response may improve outcomes for patients.
By Leigh MacMillan
1 … 41 42 43 44 45 … 67